Joan Walker to Medroxyprogesterone Acetate
This is a "connection" page, showing publications Joan Walker has written about Medroxyprogesterone Acetate.
Connection Strength
0.308
-
A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular Response. Clin Cancer Res. 2021 05 15; 27(10):2734-2741.
Score: 0.188
-
Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study. Int J Gynecol Pathol. 2014 Nov; 33(6):543-53.
Score: 0.121